In this section
How the committees work
How EMA's committees adopt an opinion or recommendation, what we publish on outcomes and the committtees' composition
Committee for Medicinal Products for Human Use (CHMP)
EMA's human medicines committee, its composition, members, meetings and agendas and outcomes
Pharmacovigilance Risk Assessment Committee (PRAC)
EMA's safety committee, its composition, members, meetings and agendas and outcomes
Committee for Veterinary Medicinal Products (CVMP)
EMA's veterinary medicines committee, its composition, members, meetings and agendas and outcomes
Committee for Orphan Medicinal Products (COMP)
EMA's orphan medicines committee, its composition, members, meetings and agendas and outcomes
Committee on Herbal Medicinal Products (HMPC)
EMA's herbal medicines committee, its composition, members, meetings and agendas and outcomes
Committee for Advanced Therapies (CAT)
EMA's advanced therapies committee, its composition, members, meetings and agendas and outcomes
European experts
EMA maintains a public list of European experts who carry out the scientific work of the Agency. This includes serving as members of the Agency's scientific committees, working parties or in assessment teams supporting their members.
European medicines regulatory network
The system for regulating medicines in Europe is unique in the world. Find out more about how it works and the role of EMA and its committees in the network.